Safety assessment of Urolithin A, a metabolite produced by the human gut microbiota upon dietary intake of plant derived ellagitannins and ellagic acid

Food and Chemical Toxicology

Volumn 108, Issue , 2017, Pages 289-297

  Heilman, Jacqueline ^a   Andreux, Pénélope ^b   Tran, Nga ^a   Rinsch, Chris ^b   Blanco Bose, William ^b  

^a EXPONENT INC   (United States)

^b EPFL   (Switzerland)

Author keywords

Ellagic acid; Ellagitannin; Pomegranate; Urolithin

Indexed keywords

3,8-DIHYDROXY-6H-DIBENZO(B,D)PYRAN-6-ONE; COUMARIN DERIVATIVE; ELLAGIC ACID; TANNIN;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; FEMALE; HUMAN; MALE; MICROFLORA; MOUSE; MUTAGEN TESTING; PHYSIOLOGY; RAT; TOXICOKINETICS;

ANIMALS; COUMARINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELLAGIC ACID; FEMALE; HUMANS; HYDROLYZABLE TANNINS; MALE; MICE; MICROBIOTA; MOLECULAR STRUCTURE; MUTAGENICITY TESTS; RATS; TOXICOKINETICS;

EID: 85027556680     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2017.07.050     Document Type: Article

References (15)

1. Cerda, B., Ceron, J.J., Tomas-Barberan, F.A., Espin, J.C., Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J. Agric. Food Chem. 51 (2003), 3493–3501.
2. Cerda, B., Espin, J.C., Parra, S., Martinez, P., Tomas-Barberan, F.A., The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur. J. Nutr. 43 (2004), 205–220.
3. Cerda, B., Periago, P., Espin, J.C., Tomas-Barberan, F.A., Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds. J. Agric. Food Chem. 53 (2005), 5571–5576.
4. Cordain, L., Miller, J.B., Eaton, S.B., Mann, N., Holt, S.H., Speth, J.D., Plant-animal subsistence ratios and macronutrient energy estimations in worldwide hunter-gatherer diets. Am. J. Clin. Nutr. 71 (2000), 682–692.
5. Espin, J.C., Larrosa, M., Garcia-Conesa, M.T., Tomas-Barberan, F., Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far. Evidence-based Complement. Altern. Med. eCAM, 2013, 2013, 270418.
6. FDA Redbook, Guidance for Industry and Other Stakeholders Toxicological Principles for the Safety Assessment of Food Ingredients. Redbook 2000, 2007.
7. Garcia-Villalba, R., Beltran, D., Espin, J.C., Selma, M.V., Tomas-Barberan, F.A., Time course production of urolithins from ellagic acid by human gut microbiota. J. Agric. Food Chem. 61 (2013), 8797–8806.
8. Gonzalez-Sarrias, A., Gimenez-Bastida, J.A., Garcia-Conesa, M.T., Gomez-Sanchez, M.B., Garcia-Talavera, N.V., Gil-Izquierdo, A., Sanchez-Alvarez, C., Fontana-Compiano, L.O., Morga-Egea, J.P., Pastor-Quirante, F.A., Martinez-Diaz, F., Tomas-Barberan, F.A., Espin, J.C., Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice. Mol. Nutr. Food Res. 54 (2010), 311–322.
9. Heber, D., Seeram, N.P., Wyatt, H., Henning, S.M., Zhang, Y., Ogden, L.G., Dreher, M., Hill, J.O., Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size. J. Agric. Food Chem. 55 (2007), 10050–10054.
10. Patel, C., Dadhaniya, P., Hingorani, L., Soni, M.G., Safety assessment of pomegranate fruit extract: acute and subchronic toxicity studies. Food Chem. Toxicol. 46 (2008), 2728–2735.
11. Ryu, D., Mouchiroud, L., Andreux, P.A., Katsyuba, E., Moullan, N., Nicolet-Dit-Felix, A.A., Williams, E.G., Jha, P., Lo Sasso, G., Huzard, D., Aebischer, P., Sandi, C., Rinsch, C., Auwerx, J., Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat. Med. 22 (2016), 879–888.
12. Seeram, N.P., Aronson, W.J., Zhang, Y., Henning, S.M., Moro, A., Lee, R.P., Sartippour, M., Harris, D.M., Rettig, M., Suchard, M.A., Pantuck, A.J., Belldegrun, A., Heber, D., Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J. Agric. Food Chem. 55 (2007), 7732–7737.
13. Tomas-Barberan, F.A., Garcia-Villalba, R., Gonzalez-Sarrias, A., Selma, M.V., Espin, J.C., Ellagic Acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. J. Agric. Food Chem. 62 (2014), 6535–6538.
14. Tomas-Barberan, F.A., Gonzalez-Sarrias, A., Garcia-Villalba, R., Nunez-Sanchez, M.A., Selma, M.V., Garcia-Conesa, M.T., Espin, J.C., Urolithins, the rescue of ‘old’ metabolites to understand a ‘new’ concept: metabotypes as a nexus between phenolic metabolism, microbiota dysbiosis and host health status. Mol. Nutr. Food Res., 61, 2016, 1500901.
15. U.S. Department of Health and Human Services, F.a.D.A., Center for Drug Evaluation and Research (CDER), Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. 2005 Guidance for Industry.